TRIMURTHI LIMITED Trimurthi Limited Share Price
Equities
TRIMURTHI6
INE314I01036
Investment Banking & Brokerage Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.04 INR | 0.00% |
|
0.00% | +60.36% |
| 28/05 | Trimurthi Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
| 28/05 | Trimurthi Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| Sales 2022 | 8.91Cr 10.69L | Sales 2023 | 1.92Cr 2L | Capitalization | 7.29Cr 9L |
|---|---|---|---|---|---|
| Net income 2022 | -2Cr -2L | Net income 2023 | - 0 | EV / Sales 2022 | 0.49 x |
| Net cash position 2022 | 2.84Cr 3L | Net cash position 2023 | 3.17Cr 4L | EV / Sales 2023 | 2.15 x |
| P/E ratio 2022 |
-3.55
x | P/E ratio 2023 |
-122
x | Employees | 7 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 19.13% |
More Fundamentals
* Assessed data
More news
| 1 month | +4.94% | ||
| 3 months | +21.40% | ||
| 6 months | +56.87% | ||
| Current year | +60.36% |
1 week
18.04
18.04
1 month
18.0418.04
Current year
8.1018.04
1 year
8.0018.04
3 years
5.3818.04
5 years
1.8518.04
10 years
1.8518.04
| Managers | Title | Age | Since |
|---|---|---|---|
Ravi Bhangadia
CEO | Chief Executive Officer | - | 09/23/09 |
Vani Manda
DFI | Director of Finance/CFO | - | 04/14/04 |
Nishita Kalantri
CMP | Compliance Officer | - | 01/19/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 04/05/04 | |
| Director/Board Member | 43 | 13/17/13 | |
| Director/Board Member | 34 | 07/16/07 |
Trimurthi Limited is an India-based company, which is engaged in the business of trading of pharmaceuticals and related products and is into the business of trading of shares and securities. The Company's segments include Pharma Business, Financial Services, Investments, Trading in Shares and Foods. Its services include distribution network for pharmaceutical products, retail pharmacy and marketing. Its products include T-SIF-O, Polyflic XT, Ulcizole-DSR, Auscomin-S, T-SIF 200, ACLO-P, LAMITAB, Oriflox, Treb-DSR, Conplus and Volivia Gold.
Calendar
07/08/2024
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +60.36% | 17.5L | |
| +3.86% | 16TCr | |
| +18.75% | 16TCr | |
| +7.92% | 14TCr | |
| +20.41% | 12TCr | |
| +7.83% | 2.49TCr | |
| +23.09% | 2.09TCr | |
| -9.28% | 1.97TCr | |
| +52.34% | 1.86TCr | |
| +4.11% | 1.56TCr |
- Stock Market
- Equities
- TRIMURTHI6 Stock
